Autopsy report · NCT07343219
Effects of Root Extract Ashwagandha (KSM-66) on Physiological Stress, Perception of Recovery and Muscle Strength in Youth Footballers
Cause of deathRegulatory or ethics
“Finalising ethics approval before completing.”
Life of this trial
- Suspended: paused, and may or may not restart.
- 62 participants enrolled.
Vital statistics
- Status
- Suspended
- Phase
- Na
- Sponsor
- Sports Performance and Applied Research in Trials and Analysis
- Sponsor type
- University, hospital or other
- Conditions
- Performance; Recovery; Strength; Aerobic Endurance
- Interventions
- Root extract Ashwagandha; Corn Starch
- Participants
- 62
- Sites
- 1
- Countries
- United Kingdom
Trials that died the same way
- Sub-Cutaneous Insulin in Hyperglycaemic Emergencies
“Ethics approval denied” - Anlotinib Hydrochloride Combined With Capeox in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer
“No approval from ethical committee” - The Effect of ACT and Float REST on Burnout Syndrome.
“Ethics Committee concerns.” - Escitalopram in Anxiety Associated Chronic Obstructive Pulmonary Disease (COPD) Exacerbations
“Study was not given ethical approval- a alternative protocol required” - Study on Leiomyosarcoma, Liposarcomas and Synovial Sarcoma With Trabectedin
“Not approved by the coordinating Ethical Committee”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.